Of 9,176 prehospital encounters for status epilepticus across 743 EMS agencies, 83.6% were treated with midazolam, 13.8% with lorazepam, and 2.7% with diazepam.

Therapeutic cooling of patients with status epilepticus did not provide neuroprotection in addition to standard of care in a new trial, but it may provide an anticonvulsive effect.

Most seizures last less than 2 minutes. Status epilepticus seizures keep going, or they come nonstop, one after another. Learn how to recognize this medical emergency.

Ceribell Inc. announced the release of ClarityPro software algorithm to address issues related to diagnosis and treatment of status epilepticus. Image: Adobe Stock ...

Silbergleit noted that about 60% to 70% of patients in status epilepticus respond to benzodiazepines, "but that means 30% to 40% do not." He explained that there has been a gap in knowing how to ...

News Release 31-Mar-2023 Status epilepticus: New inflammatory markers to improve patient care Peer-Reviewed Publication Institut du Cerveau (Paris Brain Institute) ...

About the STATUS Trial Sage designed the pivotal Phase 3 STATUS Trial to evaluate the efficacy and safety of brexanolone in patients with SRSE, ages two years or older, in the U.S., Canada and Europe.

Reference Baumann SM, De Stefano P, Kliem PSC, et al. Sex-related differences in adult patients with status epilepticus: a seven-year two-center observation. Crit Care. 2023;27 (1):308.

It is FDA-approved for adult and pediatric use in the U.S. to treat generalized tonic-clonic status epilepticus, prevent and treat seizures occurring during neurosurgery, and for substitution ...

Non-convulsive status epilepticus (NCSE) has historically been difficult to diagnose due to the lack of evidence-based criteria or consensus on electrographic patterns of status epilepticus (SE ...